- Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology
-
Choi JY, Milne S, Yunus F, Rhee CK, Matsunaga K
- KMID: 2531458
- Tuberc Respir Dis.
- 2022 Jul;85(3):279-282.
- doi: 10.4046/trd.2022.0020
-
- CITED
-
- Close
- SHARE
-
- Close
- Proven Nasal and Pulmonary Aspergillosis in Patient with Severe Fever with Thrombocytopenia Syndrome
-
Seong GM, Hyun CL, Chang SW, Yoo JR
- KMID: 2531457
- Tuberc Respir Dis.
- 2022 Jul;85(3):276-278.
- doi: 10.4046/trd.2022.0030
-
- CITED
-
- Close
- SHARE
-
- Close
- Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
-
Park S, Jung J, Kim J, Han SB, Ryoo S
- KMID: 2531454
- Tuberc Respir Dis.
- 2022 Jul;85(3):256-263.
- doi: 10.4046/trd.2021.0175
Background Mycobacterium tuberculosis (Mtb) is resistant to the β-lactam antibiotics due to a non-classical transpeptidase in the cell wall with β-lactamase activity. A recent study showed that meropenem combined with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Rapid Assessing Method of Drug Susceptibility Using Flow Cytometry for Mycobacterium tuberculosis Isolates Resistant to Isoniazid, Rifampin, and Ethambutol
-
Lee SK, Baek SH, Hong MS, Lee JS, Cho EJ, Lee JI, Cho SN, Eum SY
- KMID: 2531455
- Tuberc Respir Dis.
- 2022 Jul;85(3):264-272.
- doi: 10.4046/trd.2021.0134
Background: The current conventional drug susceptibility test (DST) for Mycobacterium tuberculosis (Mtb) takes several weeks of incubation to obtain results. As a rapid method, molecular DST requires only a few... -
- CITED
-
- Close
- SHARE
-
- Close
- Confocal Laser Endomicroscopy in a Critically Ill COVID-19 Patient
-
Danilevskaya O, Sazonov D, Klypa T, Zabozlaev F, Popova E
- KMID: 2531456
- Tuberc Respir Dis.
- 2022 Jul;85(3):273-275.
- doi: 10.4046/trd.2022.0023
-
- CITED
-
- Close
- SHARE
-
- Close
- Role of Nuclear Factor Erythroid 2-Related Factor 2 in Chronic Obstructive Pulmonary Disease
-
Ban WH, Rhee CK
- KMID: 2531450
- Tuberc Respir Dis.
- 2022 Jul;85(3):221-226.
- doi: 10.4046/trd.2021.0162
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation due to chronic airway inflammation and destruction of the alveolar structure from persistent exposure to oxidative stress. The body has... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
-
Santos NCd, Miravitlles M, Camelier AA, Almeida VDCd, Maciel RRBT, Camelier FWR
- KMID: 2531449
- Tuberc Respir Dis.
- 2022 Jul;85(3):205-220.
- doi: 10.4046/trd.2021.0179
This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Experiences of High-Risk Pulmonary Thromboembolism Receiving Extracorporeal Membrane Oxygenation in Single Institution
-
Jang J, Koo SM, Kim KU, Kim YK, Uh ST, Jang GE, Chang W, Lee BY
- KMID: 2531453
- Tuberc Respir Dis.
- 2022 Jul;85(3):249-255.
- doi: 10.4046/trd.2022.0004
Background: The main cause of death in pulmonary embolism (PE) is right-heart failure due to acute pressure overload. In this sense, extracorporeal membrane oxygenation (ECMO) might be useful in maintaining... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Antioxidant on Oxidative Stress and Autophagy in Bronchial Epithelial Cells Exposed to Particulate Matter and Cigarette Smoke Extract
-
Hur J, Rhee CK, Jo YS
- KMID: 2531452
- Tuberc Respir Dis.
- 2022 Jul;85(3):237-248.
- doi: 10.4046/trd.2021.0152
Background: We evaluated the effect of particulate matter (PM) and cigarette smoke extract (CSE) on bronchial epithelial cell survival, as well as oxidative stress and autophagy levels. Moreover, we aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
-
Nakwan N, Ruklerd T, Taptawee P
- KMID: 2531451
- Tuberc Respir Dis.
- 2022 Jul;85(3):227-236.
- doi: 10.4046/trd.2022.0038
Background: The use of low-dose inhaled corticosteroid-formoterol as reliever monotherapy has recently been recommended in the asthma treatment guidelines. However, the efficacy of this treatment strategy has not yet been... -
- CITED
-
- Close
- SHARE
-
- Close
